NCT02846233: Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? |
|
|
| Completed | N/A | 22 | US | GLP1 receptor agonist, Albiglutide (Tanzeum) or , Dulaglutide (Trulicity), basal insulin, Lantus, Toujeo, NPH, levemir, SGLT2 inhibitor, Empagliflozin (Jardiance), Metformin | University of California, San Francisco | Type 2 Diabetes Mellitus | 12/18 | 12/18 | | |
